About GlycoSpot
GlycoSpot is a company based in Frederiksberg (Denmark) founded in 2014 by Mads Hartvig Clausen and Frank Hansen. GlycoSpot has raised $3.58 million across 3 funding rounds. GlycoSpot offers products and services including MINI-LAB, The App, Enzyme Screening, and Test-Kits. GlycoSpot operates in a competitive market with competitors including GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and TFChem, among others.
- Headquarter Frederiksberg, Denmark
- Founders Mads Hartvig Clausen, Frank Hansen
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Glycospot Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.58 M (USD)
in 3 rounds
-
Latest Funding Round
$344.2 K (USD), Seed
Jun 07, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GlycoSpot
GlycoSpot offers a comprehensive portfolio of products and services, including MINI-LAB, The App, Enzyme Screening, and Test-Kits.
Handheld kit for enzyme analysis without specialized training.
Simplifies enzyme screening and R&D processes for users.
Application-specific kits for accurate enzyme activity checks.
All-inclusive sets for hassle-free enzyme testing in various fields.
Funding Insights of GlycoSpot
GlycoSpot has successfully raised a total of $3.58M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $344.2 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by GlycoSpot
Investment portfolio details for GlycoSpot
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GlycoSpot
Detailed financials for GlycoSpot
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glycospot Comparisons
Peer comparison for GlycoSpot
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GlycoSpot
GlycoSpot operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and TFChem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| Locked | Locked | Locked |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| Locked | Locked | Locked |
Reagents and assays for lipid biology research are manufactured.
|
|
| Locked | Locked | Locked |
Phospholipids and lipids are manufactured for life science applications.
|
|
| Locked | Locked | Locked |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
Detailed competitors of GlycoSpot
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glycospot
Complete news archive for GlycoSpot
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GlycoSpot
GlycoSpot was founded in 2014 and raised its 1st funding round 4 years after it was founded.
GlycoSpot is headquartered in Frederiksberg, Denmark.
GlycoSpot is a funded company, having raised a total of $3.58M across 3 funding rounds to date.
GlycoSpot was founded in 2014 in Frederiksberg, Denmark, within the biotechnology sector. Solutions for high-throughput enzyme screening are developed, focusing on dyed chromogenic polymer hydrogel substrates such as CPH-amylopectin, CPH-galactomannan, and CPH-β-glucan. Operations include standard 96-well CPH kits, Multi-CPH kits with multiple substrates per plate, and ICB substrate kits, supporting enzymatic activity assessments in research settings.
GlycoSpot's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.
GlycoSpot offers MINI-LAB, The App, Enzyme Screening, and Test-Kits.
The valuation of GlycoSpot is $6.92M as of Jun 2022.